Codiak BioSciences, based on research at the universities of Gothenburg and Texas, hoped to raise $86m in an initial public offering but has now withdrawn those plans.

Intel and Liberty Media have returned for TrapX Security's $18m series C round, having previously invested in a $14m series B that closed in 2016.

Pod Foods, which links emerging food brands to nationwide retailers, has secured seed funding from investors including Microsoft's M12 and plans to now expand across the US.

PureTech Health spinoff Karuna Therapeutics has upscaled its IPO to nearly $103m, after its shares rose by more than 50% in its first days of trading.

Mindfulness app developer Calm has added $27m to its series B round, after receiving an initial $88m tranche from investors including CAA five months ago.

Codiak Biosciences has withdrawn its proposed offering citing unfavourable market conditions, delaying an exit for investors including Alexandria Real Estate Equities.

The gas fermentation technology developer raised $30m from BP's corporate venturing unit, adding to earlier funding from the likes of Mitsui and Cargill.

Vaxess Technologies has received the final tranche of its $8.2m series A round led by MIT-affiliated incubator and venture capital fund The Engine.

Small molecule therapeutic developer Morphic, based on research at Harvard Medical School, has boosted its initial public offering from $90m to nearly $104m.

The corporate-backed small molecule therapeutic developer has boosted its initial public offering from $90m to nearly $104m.